CEO buying at Field Trip Health (:FTRP)

Joseph del Moral, CEO and Director, acquired 55,555 Common Shares on an indirect ownership basis for registered holder 2360203 Ontario Limited at a price of $4.500 through a prospectus or prospectus exempt offering on January 5th, 2021. The insider also acquired 27,777 Warrants with an exercise price of $5.600 until July 5, 2022. This represents a $249,998 investment into the company's shares and an account share holdings change of 1.0%.

Field Trip Health is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Field Trip Health Ltd., formerly Newton Energy Corporation, is engaged in the development and delivery of psychedelic therapies. Through its Field Trip Discovery, the Company develops psychedelic molecules and conducts research on plant-based psychedelics. Field Trip Discovery focuses on developing medicines targeting the serotonin 5HT2A serotonin receptor. It is also focused on developing Field Trip Health hubs for psychedelic therapies. Field Trip Health hubs are psychedelic-assisted psychotherapy centers across North America. Through its Field Trip Digital, it builds the digital and technological tools to support psychedelic experiences and consciousness expansion. The Company provides Trip, which is an iOS and Android application for consciousness expansion.